The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage

BMC Infectious Diseases

Jonathan R Carapetis²  Mark D Chatfield²  Steven YC Tong¹  Asha C Bowen² 

[1] Royal Darwin Hospital, Darwin, Northern Territory, Australia;Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia

关键词: Scabies;    Streptococcus pyogenes;    Staphylococcus aureus;    Endemic;    Tropical;    Impetigo;   

Others  :  1090001
DOI  :  10.1186/s12879-014-0727-5

 received in 2014-09-11, accepted in 2014-12-18,  发布年份 2014

【 摘 要 】

Background

Impetigo is caused by both Streptococcus pyogenes and Staphylococcus aureus; the relative contributions of each have been reported to fluctuate with time and region. While S. aureus is reportedly on the increase in most industrialised settings, S. pyogenes is still thought to drive impetigo in endemic, tropical regions. However, few studies have utilised high quality microbiological culture methods to confirm this assumption. We report the prevalence and antimicrobial resistance of impetigo pathogens recovered in a randomised, controlled trial of impetigo treatment conducted in remote Indigenous communities of northern Australia.

Methods

Each child had one or two sores, and the anterior nares, swabbed. All swabs were transported in skim milk tryptone glucose glycogen broth and frozen at –70°C, until plated on horse blood agar. S. aureus and S. pyogenes were confirmed with latex agglutination.

Results

From 508 children, we collected 872 swabs of sores and 504 swabs from the anterior nares prior to commencement of antibiotic therapy. S. pyogenes and S. aureus were identified together in 503/872 (58%) of sores; with an additional 207/872 (24%) sores having S. pyogenes and 81/872 (9%) S. aureus, in isolation. Skin sore swabs taken during episodes with a concurrent diagnosis of scabies were more likely to culture S. pyogenes (OR 2.2, 95% CI 1.1 – 4.4, p = 0.03). Eighteen percent of children had nasal carriage of skin pathogens. There was no association between the presence of S. aureus in the nose and skin. Methicillin-resistance was detected in 15% of children who cultured S. aureus from either a sore or their nose. There was no association found between the severity of impetigo and the detection of a skin pathogen.

Conclusions

S. pyogenes remains the principal pathogen in tropical impetigo; the relatively high contribution of S. aureus as a co-pathogen has also been confirmed. Children with scabies were more likely to have S. pyogenes detected. While clearance of S. pyogenes is the key determinant of treatment efficacy, co-infection with S. aureus warrants consideration of treatment options that are effective against both pathogens where impetigo is severe and prevalent.

Trial registration

This trial is registered; ACTRN12609000858291 webcite.

【 授权许可】

   
2014 Bowen et al.; licensee BioMed Central.

【 参考文献 】

• [1]Currie BJ, Carapetis JR: Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol 2000, 41(3):139-143. quiz 144-135
• [2]Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC, Berger M, van der Wouden JC: Interventions for impetigo. Cochrane Database Syst Rev 2012, 1:CD003261.
• [3]Geria AN, Schwartz RA: Impetigo update: new challenges in the era of methicillin resistance. Cutis 2010, 85(2):65-70.
• [4]Carapetis JR, Steer AC, Mulholland EK, Weber M: The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5(11):685-694.
• [5]Parks T, Smeesters PR, Steer AC: Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis 2012, 25(2):145-153.
• [6]Abdel Fattah NS, Darwish YW: Antibiogram testing of pediatric skin infections in the era of methicillin-resistant Staphylococci aureus: an Egyptian University Hospital-based study. Int J Dermatol 2012, 51(12):1441-1447.
• [7]Alvarez-Uria G, Reddy R: Prevalence and antibiotic susceptibility of community-associated methicillin-resistant staphylococcus aureus in a rural area of india: is MRSA replacing methicillin-susceptible staphylococcus aureus in the community? ISRN Dermatol 2012, 2012:248951.
• [8]Steer AC, Jenney AW, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L, Mulholland EK, Carapetis JR: High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis 2009, 3(6):e467.
• [9]Bowen AC, Tong SYC, Andrews RM, O'Meara IM, McDonald MI, Chatfield MD, Currie BJ, Carapetis JR: Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial.Lancet 2014, 384(9960):2132–2140.
• [10]Bowen AC, Lilliebridge RA, Tong SY, Baird RW, Ward P, McDonald MI, Currie BJ, Carapetis JR: Is streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole? J Clin Microbiol 2012, 50(12):4067-4072.
• [11]Svartman M, Finklea JF, Earle DP, Potter EV, Poon-King T: Epidemic scabies and acute glomerulonephritis in Trinidad. Lancet 1972, 1(7744):249-251.
• [12]Taplin D, Porcelain SL, Meinking TL, Athey RL, Chen JA, Castillero PM, Sanchez R: Community control of scabies: a model based on use of permethrin cream. Lancet 1991, 337(8748):1016-1018.
• [13]Carapetis JR, Connors C, Yarmirr D, Krause V, Currie BJ: Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J 1997, 16(5):494-499.
• [14]Valery PC, Wenitong M, Clements V, Sheel M, McMillan D, Stirling J, Sriprakash KS, Batzloff M, Vohra R, McCarthy JS: Skin infections among Indigenous Australians in an urban setting in far North Queensland. Epidemiol Infect 2008, 136(8):1103-1108.
• [15]McDonald MI, Towers RJ, Andrews RM, Benger N, Currie BJ, Carapetis JR: Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006, 43(6):683-689.
• [16]Jenney A, Holt D, Ritika R, Southwell P, Pravin S, Buadromo E, Carapetis J, Tong S, Steer A: The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji. BMC Infect Dis 2014, 14(1):160. BioMed Central Full Text
• [17]Iovino SM, Krantz KD, Blanco DM, Fernandez JA, Ocampo N, Najafi A, Memarzadeh B, Celeri C, Debabov D, Khosrovi B, Anderson M: NVC-422 topical gel for the treatment of impetigo. Int J Clin Exp Pathol 2011, 4(6):587-595.
• [18]Phakade RS, Nataraj G, Kuyare SS, Khopkar US, Mehta PR: Is methicillin-resistant Staphylococcus aureus involved in community acquired skin and soft tissue infections? Experience from a tertiary care centre in Mumbai. J Postgrad Med 2012, 58(1):3-7.
• [19]McDonald M, Dougall A, Holt D, Huygens F, Oppedisano F, Giffard PM, Inman-Bamber J, Stephens AJ, Towers R, Carapetis JR, Currie BJ: Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol 2006, 44(10):3720-3727.
• [20]Tong SY, Varrone L, Chatfield MD, Beaman M, Giffard PM: Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012.Epidemiol Infect 2014, 1–5.
• [21]Barrow GI: Clinical and bacteriological aspects of impetigo contagiosa. J Hyg (Lond) 1955, 53(4):495-508.
• [22]Hughes WT, Wan RT: Impetigo contagiosa: etiology, complications, and comparison of therapeutic effectiveness of erythromycin and antibiotic ointment. Am J Dis Child 1967, 113(4):449-453.
• [23]Masters PL, Brumfitt W, Mendez RL, Likar M: Bacterial flora of the upper respiratory tract in Paddington families. 1952-4. Br Med J 1958, 1(5081):1200-1205.
• [24]Wasserzug O, Valinsky L, Klement E, Bar-Zeev Y, Davidovitch N, Orr N, Korenman Z, Kayouf R, Sela T, Ambar R, Derazne E, Dagan R, Zarka S: A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes. Clin Infect Dis 2009, 48(9):1213-1219.
• [25]Barth JH: Nasal carriage of staphylococci and streptococci. Int J Dermatol 1987, 26(1):24-26.
• [26]Ellis MW, Griffith ME, Dooley DP, McLean JC, Jorgensen JH, Patterson JE, Davis KA, Hawley JS, Regules JA, Rivard RG, Gray PJ, Ceremuga JM, Sejoseph MA, Hospenthal DR: Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother 2007, 51(10):3591-3598.
• [27]Belcher DW, Afoakwa SN, Osei-Tutu E, Wurapa FK, Osei L: Letter: Non-group A streptococci in Ghanaian patients with pyoderma. Lancet 1975, 2(7943):1032.
• [28]Lawrence DN, Facklam RR, Sottnek FO, Hancock GA, Neel JV, Salzano FM: Epidemiologic studies among Amerindian populations of Amazonia. I. Pyoderma: prevalence and associated pathogens. Am J Trop Med Hyg 1979, 28(3):548-558.
• [29]Bowen AC, Tong SY, Chatfield MD, Andrews RM, Carapetis JR: Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia. Trans R Soc Trop Med Hyg 2013, 107(6):384-389.
• [30]Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement M100-S24. Clinical and Laboratory Standards Institute, Wayne; 2014.
• [31]Tong SY, Bishop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, Holt DC, Giffard PM, McDonald MI, Currie BJ, Boutlis CS: Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis 2009, 199(10):1461-1470.